NLS PHARMACEUTICS LTD (NLSP) Stock Balance Sheet
NASDAQ:NLSP - Nasdaq - CH1384053976 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 552.80K | 897.70K | 8.95M | 5.43M | 90.00K | |||
| Receivables | 81.10K | 35.10K | 40.00K | 40.00K | 60.00K | |||
| Other Current Assets | 558.70K | 890.30K | 260.00K | 250.00K | 40.00K | |||
| Total Current Assets | 1.19M | 1.82M | 9.25M | 5.72M | 200.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.00K | 6.70K | 20.00K | 30.00K | N/A | |||
| Other Non-Current Assets | 0.00 | 16.90K | 10.00K | 10.00K | 950.00K | |||
| Total Non-Current Assets | 1.00K | 23.50K | 30.00K | 40.00K | 1.01M | |||
| TOTAL ASSETS | 1.19M | 1.85M | 9.28M | 5.76M | 1.21M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.71M | 1.63M | 0.00 | 0.00 | 1.16M | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 610.00K | |||
| Accrued Expenses | 1.42M | 1.65M | 990.00K | 670.00K | 1.43M | |||
| Accounts Payable | 4.58M | 4.63M | 2.37M | 1.74M | 4.01M | |||
| Total Current Liabilities | 7.72M | 7.92M | 3.36M | 2.40M | 7.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 310.00K | |||
| Other Non-Current Liabilities | 2.74M | 2.76M | 2.64M | 2.82M | 2.68M | |||
| Total Non-Current Liabilities | 2.74M | 2.76M | 2.64M | 2.82M | 3.00M | |||
| TOTAL LIABILITIES | 10.46M | 10.68M | 6.00M | 5.22M | 10.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -72.41M | -70.37M | -58.20M | -41.71M | -29.76M | |||
| Additional Paid In Capital | 62.33M | 61.03M | 60.86M | 42.08M | 20.65M | |||
| Common Shares | 808.60K | 733.40K | 670.00K | 340.00K | 150.00K | |||
| Treasury Stock | N/A | -64.90K | 0.00 | -30.00K | N/A | |||
| Other Shareholders' Equity | 4.20K | -158.10K | -50.00K | -150.00K | -20.00K | |||
| Shares Outstanding | 985.70K | 810.70K | 32.43M | 16.22M | 11.78M | |||
| Tangible Book Value per Share | -9.40 | -10.90 | 0.10 | 0.03 | -0.76 | |||
| Total Shareholders' Equity | -9.27M | -8.83M | 3.28M | 540.00K | -8.98M | |||
| TOTAL LIABILITIES AND EQUITY | 1.19M | 1.85M | 9.28M | 5.76M | 1.21M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.16 | |||
| Current Ratio | 0.15 | 0.23 | 2.75 | 2.38 | 0.03 | |||
| Return On Assets (ROA) | -552.58% | -659.16% | -177.80% | -207.47% | -236.36% | |||
| Return On Equity (ROE) | N/A | N/A | -503.05% | -2212.96% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21